Literature DB >> 1117319

The fine structure of the cervical spinal cord, ventral root and brachial nerves in the wobbler (wr) mouse.

J M Andrews.   

Abstract

Much indirect evidence supports the prevailing concept that the wobbler mouse represents an inherited form of lower motor neuron degeneration, with resultant neurogenic muscular atrophy, due to an autosomal recessive gene (wr). This report, which emphasizes the fine structural changes in the wobbler mouse cervical spinal cord, ventral root and brachial nerves, both extends and modifies previously published data concerning the ultrastructural changes in this disorder. In addition to the more obvious neuronal cytoplasmic vacuolization known to occur, studies extended to a broader age range of wobbler mice have revealed neuronal alterations such as nonvacuolar dissolution of granular endoplasmic reticulum, proliferation of cytoplasmic microtubules and neurofilaments, proliferation of branched tubules resembling smooth endoplasmic reticulum, development of lipid droplets, and increased numbers of pleomorphic dense and lamellar cytoplasmic bodies. The spectrum of pathological changes in this murine form of motor neuron disease thus appears more complex and varied than has hitherto been appreciated, and may be relevant to the formulation of pathogenetic hypotheses.

Entities:  

Mesh:

Year:  1975        PMID: 1117319     DOI: 10.1097/00005072-197501000-00002

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  10 in total

1.  Neuron volume in the ventral horn in Wobbler mouse motoneuron disease: a light microscope stereological study.

Authors:  P Dockery; Y Tang; M Morais; L L Vacca-Galloway
Journal:  J Anat       Date:  1997-07       Impact factor: 2.610

2.  The structure and composition of peripheral nerves and nerve roots in the Sprawling mouse.

Authors:  L W Duchen; F Scaravilli
Journal:  J Anat       Date:  1977-07       Impact factor: 2.610

3.  Reduction of lower motor neuron degeneration in wobbler mice by N-acetyl-L-cysteine.

Authors:  J T Henderson; M Javaheri; S Kopko; J C Roder
Journal:  J Neurosci       Date:  1996-12-01       Impact factor: 6.167

4.  A study of cerebellar and cerebral cortical degeneration in miniature poodle pups with emphasis on the ultrastructure of Purkinje cell changes.

Authors:  J F Cummings; A de Lahunta
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

Review 5.  The wobbler mouse: a neurodegeneration jigsaw puzzle.

Authors:  Séverine Boillée; Marc Peschanski; Marie-Pierre Junier
Journal:  Mol Neurobiol       Date:  2003-08       Impact factor: 5.590

6.  Neutral Lipid Cacostasis Contributes to Disease Pathogenesis in Amyotrophic Lateral Sclerosis.

Authors:  James C Dodge; Elizabeth H Jensen; Jinlong Yu; S Pablo Sardi; Allison R Bialas; Tatyana V Taksir; Dinesh S Bangari; Lamya S Shihabuddin
Journal:  J Neurosci       Date:  2020-10-13       Impact factor: 6.167

7.  Immunohistological analyses of neutral glycosphingolipids and gangliosides in normal mouse skeletal muscle and in mice with neuromuscular diseases.

Authors:  M Cacic; K Sostarić; S Weber-Schürholz; J Müthing
Journal:  Glycoconj J       Date:  1995-10       Impact factor: 2.916

8.  Ballooned neurons in select neurodegenerative diseases contain phosphorylated neurofilament epitopes.

Authors:  D W Dickson; S H Yen; K I Suzuki; P Davies; J H Garcia; A Hirano
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

9.  Neuromuscular degeneration (nmd): a mutation on mouse chromosome 19 that causes motor neuron degeneration.

Authors:  S A Cook; K R Johnson; R T Bronson; M T Davisson
Journal:  Mamm Genome       Date:  1995-03       Impact factor: 2.957

Review 10.  Molecular chaperones, cochaperones, and ubiquitination/deubiquitination system: involvement in the production of high quality spermatozoa.

Authors:  Rosaria Meccariello; Rosanna Chianese; Vincenza Ciaramella; Silvia Fasano; Riccardo Pierantoni
Journal:  Biomed Res Int       Date:  2014-06-19       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.